With Prime Minister Narendra Modi-led BJP failing to secure a simple majority on its own in the Lok Sabha election, global brokerage firm CLSA has tweaked its India portfolio to make it more defensive. It has replaced L&T with HCL Tech in India-focus portfolio. “Recognising these uncertainties, we take out L&T from our India focus … Read more
Brokerage Macquarie maintained an outperform rating on Aurobindo Pharma, Morgan Stanley initiated coverage on Suzlon, CLSA upgraded Apollo Hospital and CLSA maintained a buy rating on Titan Company. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: Macquarie on Aurobindo Pharma: Outperform | Target Rs 1,385Macquarie maintained an … Read more
FMCG major ITC left investors little to chew on in its March quarter results with the shares falling nearly 1% to Rs 437.85 on BSE during the day but brokerages have raised target prices going up to Rs 540. Global brokerage firm Citi, which has a buy call on ITC, raised its target price to … Read more
Mumbai: Shares of logistics solutions provider Delhivery tumbled over 10% on Tuesday after the company’s fourth-quarter results prompted some brokerages, including CLSA, to cut their price targets on the stock. The price targets after the March quarter results imply a 15-74% upside in the stock from Tuesday’s closing price of ₹390. CLSA downgraded its rating … Read more
We have collated a list of recommendations from top brokerage firms from ETNow and other sources: CLSA on Delhivery: Underperform| Target Rs 488CLSA downgraded Delhivery to underperform from buy earlier post-Q4 results and slashed the target price to Rs 488 from Rs 600 earlier. The Q4 revenue growth was below expectations. Express parcel revenue declined … Read more
Brokerage JPMorgan maintained an overweight rating on SBI and Macquarie upgraded Escorts to outperform. CLSA downgraded Sula to underperform while maintaining a sell on Asian Paints post Q4 results. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: JPMorgan on SBI: Overweight| Target Rs 1000 JPMorgan maintained an … Read more
“You can see from foreign flows perspective that that rebound in China is detracting from some of the investment in India. I do not think it changes the longer-term trends, but we are in one of those holding patterns similar to the fourth quarter of 2023,” says Laurence Balanco, CLSA.What is the take on India … Read more
CLSA’s downgrade of Indian IT bellwether Tata Consultancy Services (TCS) and HCL Technologies did not go down well with the investors, triggering a selling spree in most IT stocks. Both TCS and HCL Tech shares fell 2% in Tuesday’s trade. The Hong Kong-based brokerage downgraded TCS to ‘Sell’ for the price target of Rs 3,925 … Read more
Brokerage firm CLSA maintained a buy rating on RIL, Goldman Sachs downgraded ONGC, BPCL, and IOC. Jefferies has a buy rating on Godrej Consumer and Nuvama upgraded Infosys to buy ahead of Q3 results. We have collated a list of recommendations from top brokerage firms from ETNow and other sources: CLSA on RIL: Buy| Target … Read more
